|
|
Commonwealth Biotechnologies Acquires China Peptide Producer
publication date: Jun 10, 2009
Commonwealth Biotechnologies, Inc. has agreed to acquire privately owned GL Biochem (Shanghai) Ltd., a manufacturer of peptide products and reagents. In 2008, GL Biochem produced $13 million of revenue and $2 million of net income, representing a compound annual growth rate of 40%. In an all-stock transaction, CBI will issue 6.56 million shares to owners of GL Biochem, which will give them 51% ownership of CBI. More details... Stock Symbol: (NSDQ: CBTE)
|
ChinaBio® Events
ChinaBio® Partnering Forum 2012May 23-24, 2012 Suzhou, China >>More events...
Partner Events
 China Healthcare Investment Conference 2012March 13-15, 2012 Shanghai, China Shanghai CEO ConferenceMarch 28-29, 2012 Shanghai, China >>More details...
Other Events
China Pharmaceutical R&D SummitApril 23-26, 2012 Shanghai, China Biosimilars Asia 2012April 23-26, 2012 Shanghai, China Vaccines China 2012April 23-26, 2012 Shanghai, China
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners
![]()
|